Corrigendum to “Danggui Shaoyao San ameliorates the lipid metabolism via the PPAR signaling pathway in a Danio rerio (zebrafish) model of hyperlipidemia” [Biomed. Pharmacother. 168 (2023) 115736] - 05/01/24
Doi : 10.1016/j.biopha.2023.115964
Yuke Wang a, b, Ying Pan a, Mirong Hou a, Rongsiqing Luo a, b, Jiawei He a, b, Fan Lin a, Xiaofang Xia a, Ping Li a, b, Chunxiang He a, b, Pan He d, Shaowu Cheng a, b 
, Zhenyan Song a, b, c
, Zhenyan Song a, b, c a School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, Hunan, China
b Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, Hunan, China
c National Key Laboratory Cultivation Base of Chinese Medicinal Powder & Innovative Medicinal Jointly Established by Province and Ministry, Changsha 410208, Hunan, China
d Research Institute of Zhong Nan Grain and Oil Foods, Changsha 410208, Hunan, China
Le texte complet de cet article est disponible en PDF.
© 2023
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 170
Article 115964- janvier 2024 Retour au numéro
Article précédent
- Reversible SAHH inhibitor ameliorates MIA-induced osteoarthritis of rats through suppressing MEK/ERK pathway
- Shu-Hui Fan, Yuan Chang, Xiao-Yu Xiong, Mai Xiang, Wen-Long Yuan, Xiao-Qian Yang, Wen-Hui Wei, Li Chen, Meng-Nan Cheng, Feng-Hua Zhu, Shi-Jun He, Jian-Ping Zuo, Ze-Min Lin
- Corrigendum to “Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice.” [Biomed. Pharmacother. 150 (2022) 112936]
- Duoduo Zhang, Pengmin Ji, Ran Sun, Huimin Zhou, Lei Huang, Liangliang Kong, Weiping Li, Weizu Li
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?